Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2395]
News [5726]
Articles [139]
Editorials [4]
Conferences [165]
elearning [13]
Understanding the use of PARPi combinations to treat patients with mCRPC
Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof...
Understanding the use of PARPi combinations to treat patients with mCRPC ( Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard )
15 Sep 2024
TACE combined with lenvatinib-pembrolizumab shows improved PFS in intermediate...
Prof Josep Llovet - Hospital Clinic Barcelona, Barcelona, Spain
TACE combined with lenvatinib-pembrolizumab shows improved PFS in intermediate stage liver cancer ( Prof Josep Llovet - Hospital Clinic Barcelona, Barcelona, Spain )
15 Sep 2024
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof...
ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )
15 Sep 2024
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...
Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
Trastuzumab deruxtecan effective against brain metastases in HER2-positive...
Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear cell RCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
Status of anti BCMA therapy in myeloma
Dr Dibakar Podder - Tata Medical Center, Kolkata, India
Status of anti BCMA therapy in myeloma ( Dr Dibakar Podder - Tata Medical Center, Kolkata, India )
9 Sep 2024
The promise of CAR T cell therapy for multiple myeloma
Dr Dibakar Podder - Tata Medical Center, Kolkata, India
The promise of CAR T cell therapy for multiple myeloma ( Dr Dibakar Podder - Tata Medical Center, Kolkata, India )
8 Sep 2024
Multiple myeloma In Rwanda: The need for further research
Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda
Multiple myeloma In Rwanda: The need for further research ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )
6 Aug 2024
Addressing the rise of multiple myeloma in Rwanda
Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda
Addressing the rise of multiple myeloma in Rwanda ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )
6 Aug 2024
Durable responses in aRCC, how do we optimise treatment?
Prof Roberto Iacovelli and Prof Viktor Grünwald
Durable responses in aRCC, how do we optimise treatment? ( Prof Roberto Iacovelli and Prof Viktor Grünwald )
29 Jul 2024
Bladder cancer updates from the first half of 2024
Prof Alison Birtle, Dr Ignacio Durán, Dr Patrizia Giannatempo
Bladder cancer updates from the first half of 2024 ( Prof Alison Birtle, Dr Ignacio Durán, Dr Patrizia Giannatempo )
26 Jul 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation